Four phase 3 trials at ESMO 2026 brought news for people with small cell, EGFR, MET and KRAS G12C lung cancer, plus a caution ...

A new meta-analysis provided high-quality evidence demonstrating that video-assisted thoracoscopic surgery (VATS) significantly reduces the risk for death by 21% compared with open lobectomy in ...

Overall cancer death rates fell 1.6%/year in males and 1.1%/year in females from 2019–2023, while lung cancer deaths declined 4.7%/year and 3.0%/year, respectively. Lung cancer incidence decreased 3.5 ...

There is more hope than ever for people diagnosed with the deadliest cancer. Declines in smoking and the advent of screening and newer drugs have transformed the outlook for patients with lung cancer, ...

Lung cancer is still a leading cause of cancer death, but that rate is half what it was in the 1990s, partly because newly developed treatments are working.

The Phase 3 clinical trial of combination treatment for advanced lung cancer made by Amgen and AstraZeneca showed promise in ...